[Differing acute effects of propranolol on the hypertensive heart during exercise]. 1986

W D Purfürst, and K H Günther, and W Hujer, and H Siewert, and D Strangfeld

Exercise investigations were performed in 39 male hypertensives (WHO stage I-III) to assess haemodynamics and cardiac function after intravenous application of 5 mg propranolol for the detection of latent heart failure. Radiocardiography was used to determine volumetric parameters such as LV end-diastolic volume and ejection fraction, and microcatheterization was employed to obtain the LV filling pressure via pressure measurement in the pulmonary artery (PA). The negative inotropic and chronotropic effects of propranolol on pump function and myocardial mechanics at rest were found to be minimal. During 50 watt exercise however, an increase of the diastolic PA pressure has been observed simultaneously with a diminution of cardiac output (stroke volume being constant). Thus, under acutely administered beta blockade, a general disturbance in the flow-pressure relation could be induced, being comparable to heart failure. Only in a few cases was the reduced contractility compensated by the Frank-Starling mechanism, but only if the mechanism did not participate in the regulation of pump function during the previous control investigation. In other cases a remarkable reduction of cardiac output and even stroke volume occurred, results which may be explained as a consequence of a reduced venous return (or pooling) connected with acutely induced vascular effects (beta-2 blockade).

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D002306 Cardiac Volume The volume of the HEART, usually relating to the volume of BLOOD contained within it at various periods of the cardiac cycle. The amount of blood ejected from a ventricle at each beat is STROKE VOLUME. Heart Volume,Cardiac Volumes,Heart Volumes,Volume, Cardiac,Volume, Heart,Volumes, Cardiac,Volumes, Heart
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts

Related Publications

W D Purfürst, and K H Günther, and W Hujer, and H Siewert, and D Strangfeld
April 1990, Medicine and science in sports and exercise,
W D Purfürst, and K H Günther, and W Hujer, and H Siewert, and D Strangfeld
May 1985, International journal of clinical pharmacology, therapy, and toxicology,
W D Purfürst, and K H Günther, and W Hujer, and H Siewert, and D Strangfeld
May 1987, Clinical pharmacology and therapeutics,
W D Purfürst, and K H Günther, and W Hujer, and H Siewert, and D Strangfeld
September 2000, The Journal of pharmacology and experimental therapeutics,
W D Purfürst, and K H Günther, and W Hujer, and H Siewert, and D Strangfeld
January 1979, British heart journal,
W D Purfürst, and K H Günther, and W Hujer, and H Siewert, and D Strangfeld
August 1987, Journal of hypertension,
W D Purfürst, and K H Günther, and W Hujer, and H Siewert, and D Strangfeld
March 1993, Clinical physiology (Oxford, England),
W D Purfürst, and K H Günther, and W Hujer, and H Siewert, and D Strangfeld
July 1979, The American journal of cardiology,
W D Purfürst, and K H Günther, and W Hujer, and H Siewert, and D Strangfeld
November 1986, Equine veterinary journal,
W D Purfürst, and K H Günther, and W Hujer, and H Siewert, and D Strangfeld
January 1998, Proceedings of the Western Pharmacology Society,
Copied contents to your clipboard!